According to the research report titled ‘Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country: Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)’, available with Market Study Report, global psoriasis treatment market was appraised at USD 16.7 billion in 2019 and is expected to grow significantly during the study period.
 

Increased pervasiveness of psoriasis and improving cognizance regarding the disease management are some of the major factors driving the growth of global psoriasis treatment market. Growing demand for advanced healthcare products and rising number of pipeline drugs are also contributing towards the market dynamics.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2827956/
 

Rising elderly population, supportive regulatory outlook, rising adoption of unhealthy lifestyle are adding traction to global psoriasis treatment industry size. This widespread adoption of unhealthy lifestyle and mounting consumption of alcohol and tobacco has resulted in psoriasis as well as psoriasis arthritis.
 

On the contrary, the advent of COVID-19 has had a severe impact on the market growth, with several business compelled to postpone their relative projects in order to prioritize treating Coronavirus patients.
 

As per type, the report states that plaque psoriasis segment is likely to generate considerable revenues for the overall market in the ensuing years. Focus towards developing advanced medications for treating plaque psoriasis is fueling the segmental share.
 

Moving on to treatment type, the biologics segment is expected to capture the highest share in global psoriasis treatment industry. Increasing emphasis among market majors towards R&D activities in order to develop advanced biologics and biosimilars are promoting the overall business outlook.
 

From the regional point of view, although North America currently holds the largest market share, Asia-Pacific is likely to emerge as one of the key revenue contributors for this business space. Growing occurrence of psoriasis, escalating healthcare expenditure, and favorable government initiatives are favoring the regional market outlook.
 

The competitive landscape of global psoriasis treatment market is defined by companies such as Johnson & Johnson, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Abbvie Inc., Bausch Health Companies Inc., Almirall S.A., Boehringer Ingelheim, Sun Pharmaceutical Industries Limited, and UCB among others.